FDA Inspection 1051716 — Wyeth Pharmaceutical Division Of Wyeth Holdings LLC

Wyeth Pharmaceutical Division Of Wyeth Holdings LLC — FEI 1000110954

The FDA completed an inspection of Wyeth Pharmaceutical Division Of Wyeth Holdings LLC on Apr 19, 2018 in Sanford, NC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Apr 19, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Sanford, NC (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.